Hubei Biocause Heilen Pharmaceutical Co. Ltd. Net Asset Momentum
Hubei Biocause Heilen Pharmaceutical Co. Ltd. net asset momentum. Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) recorded a net asset momentum of -1.6% as of December 2025, with net assets of CN¥2.27 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Hubei Biocause Heilen Pharmaceutical Co. for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Hubei Biocause Heilen Pharmaceutical Co. Ltd. (2017–2025)
Net asset momentum of Hubei Biocause Heilen Pharmaceutical Co. Ltd. from 2017 to 2025. This chart tracks Hubei Biocause Heilen Pharmaceutical Co. Ltd.'s year-over-year net asset growth across 9 annual reporting periods from 2017 to 2025. The most recent momentum reading is -1.6%, with net assets of CN¥2.27 Billion CNY as of December 2025. Check Hubei Biocause Heilen Pharmaceutical Co. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Net Asset Momentum by Year (2017–2025)
Hubei Biocause Heilen Pharmaceutical Co. Ltd. net asset momentum by year from 2017 to 2025. The table below shows the complete annual net asset history for Hubei Biocause Heilen Pharmaceutical Co. Ltd. from 2017 to 2025, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Hubei Biocause Heilen Pharmaceutical Co. market cap and net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥2.27 Billion | CN¥2.40 Billion | CN¥128.65 Million | ▼ -1.6% |
| 2024 | CN¥2.31 Billion | CN¥2.49 Billion | CN¥178.97 Million | ▼ -2.0% |
| 2023 | CN¥2.36 Billion | CN¥2.55 Billion | CN¥189.89 Million | ▲ +3.5% |
| 2022 | CN¥2.28 Billion | CN¥2.50 Billion | CN¥221.22 Million | ▲ +2.4% |
| 2021 | CN¥2.22 Billion | CN¥2.33 Billion | CN¥107.53 Million | ▲ +217.4% |
| 2020 | CN¥700.39 Million | CN¥803.25 Million | CN¥102.85 Million | ▲ +43.4% |
| 2019 | CN¥488.25 Million | CN¥745.56 Million | CN¥257.31 Million | ▲ +22.1% |
| 2018 | CN¥399.87 Million | CN¥640.24 Million | CN¥240.36 Million | ▲ +30.0% |
| 2017 | CN¥307.65 Million | CN¥534.90 Million | CN¥227.25 Million | — |